AI assistant
CONMED Corp — Director's Dealing 2020
Jun 3, 2020
31971_dirs_2020-06-03_26af3c5d-d27a-4495-b78d-ba065bb318d5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2020-06-01
Reporting Person: Schwarzentraub Barbara J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-06-01 | Rsus (restricted Stock Units) | $0 | A | 1521 | Acquired | 2030-06-01 | Common Stock (1521) | Direct |
| 2020-06-01 | Options To Purchase Common Stock | $73.94 | A | 1843 | Acquired | 2030-06-01 | Common Stock (1843) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
F2: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.